These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19250671

  • 21. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.
    J Natl Cancer Inst; 2009 Jul 01; 101(13):916-27. PubMed ID: 19535783
    [Abstract] [Full Text] [Related]

  • 22. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman JG, Osieka R, Galm O.
    Br J Haematol; 2008 Sep 01; 142(5):745-53. PubMed ID: 18537968
    [Abstract] [Full Text] [Related]

  • 23. Tuberin regulates the DNA repair enzyme OGG1.
    Habib SL, Riley DJ, Mahimainathan L, Bhandari B, Choudhury GG, Abboud HE.
    Am J Physiol Renal Physiol; 2008 Jan 01; 294(1):F281-90. PubMed ID: 17989114
    [Abstract] [Full Text] [Related]

  • 24. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
    Rethmeier A, Aggerholm A, Olesen LH, Juhl-Christensen C, Nyvold CG, Guldberg P, Hokland P.
    Br J Haematol; 2006 May 01; 133(3):276-83. PubMed ID: 16643429
    [Abstract] [Full Text] [Related]

  • 25. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
    Younan S, Elhoseiny S, Hammam A, Gawdat R, El-Wakil M, Fawzy M.
    Leuk Res; 2012 Feb 01; 36(2):169-73. PubMed ID: 21978468
    [Abstract] [Full Text] [Related]

  • 26. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Qin Y, Zhu H, Jiang B, Li J, Lu X, Li L, Ruan G, Liu Y, Chen S, Huang X.
    Leuk Res; 2009 Mar 01; 33(3):384-90. PubMed ID: 18950857
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D.
    J Clin Oncol; 2009 Nov 01; 27(31):5195-201. PubMed ID: 19752335
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
    Lugnier C, Majores M, Fassunke J, Pernhorst K, Niehusmann P, Simon M, Nellist M, Schoch S, Becker A.
    J Neuropathol Exp Neurol; 2009 Oct 01; 68(10):1136-46. PubMed ID: 19918125
    [Abstract] [Full Text] [Related]

  • 35. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
    Nellist M, Burgers PC, van den Ouweland AM, Halley DJ, Luider TM.
    Biochem Biophys Res Commun; 2005 Aug 05; 333(3):818-26. PubMed ID: 15963462
    [Abstract] [Full Text] [Related]

  • 36. Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway.
    Jiang X, Yeung RS.
    Cancer Res; 2006 May 15; 66(10):5258-69. PubMed ID: 16707451
    [Abstract] [Full Text] [Related]

  • 37. Management of epilepsy in tuberous sclerosis complex.
    Curatolo P, D'Argenzio L, Cerminara C, Bombardieri R.
    Expert Rev Neurother; 2008 Mar 15; 8(3):457-67. PubMed ID: 18345974
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA, Carraro DM, Brentani HP, Kaiano JH, Simão DF, Guarnieiro R, Lopes LF, Borojevic R, Brentani MM.
    Leuk Res; 2007 May 15; 31(5):579-89. PubMed ID: 17092558
    [Abstract] [Full Text] [Related]

  • 40. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.
    Devlin LA, Shepherd CH, Crawford H, Morrison PJ.
    Dev Med Child Neurol; 2006 Jun 15; 48(6):495-9. PubMed ID: 16700943
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.